U.S. District Judge Richard Leon said that the FDA violated its policies by allowing sodium thiopental into the country without first ensuring its safety and effectiveness. Mr. Leon called the anesthetic a misbranded and unapproved drug, ordering Arizona, California, Georgia, South Carolina and Tennessee and any other states in possession of the drug to return it to the FDA.
“Prisoners on death row have an unnecessary risk that they will not be anesthetized properly prior to execution,” Mr. Leon wrote.
Related Articles on Anesthesia:
Study: Dexamethasone Effectively Reduces Postoperative Nausea
I-Flow Launches Peripheral Nerve Block Kits
3 Reasons Why Anesthesia Providers Should Lead the OR
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
